ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Recipharm, Arcturus Ink LUNAR-COV19 Vax Mfg. Pact
October 10, 2020Recipharm to support the manufacture of ARCT-021, Arcturus’ COVID-19 vaccine candidate that is in an ongoing Phase I/II clinical trial. -
Arcturus agrees to supply potential Covid-19 vaccine to Israel
July 27, 2020US-based mRNA medicines company Arcturus Therapeutics has signed a binding term sheet with the Israeli Ministry of Health to supply its potential Covid-19 vaccine, LUNAR-COV19. -
Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
May 30, 2018SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT) ("Arcturus" or the "Company), a leading RNA medicines company, today announced that,
Pharma Sources Insight January 2025
